Publication | Closed Access
Efficacy and toxicity of compassionate ibrutinib use in relapsed/refractory chronic lymphocytic leukemia in Poland: analysis of the Polish Adult Leukemia Group (PALG)
39
Citations
4
References
2017
Year
Clinical EndpointPharmacotherapyAdverse Drug ReactionHematological MalignancyOncologyAdverse EventHematologyClinical TrialsCancer ResearchHealth SciencesClinical Trial ManagementOutcomes ResearchRoutine Clinical PracticePharmacologyAdverse EventsMalignant Blood DisorderPatient SafetyDrug TrialCompassionate Ibrutinib UseMedicineClinical Trial EvaluationSpecific TherapyClinical Trial DesignEmergency Medicine
It is widely understood that outcomes of specific therapy and the burden of adverse events (AEs) found in clinical trials may differ from those seen in routine clinical practice. Several clinical t...
| Year | Citations | |
|---|---|---|
Page 1
Page 1